Neurology
RSSArticles
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions. -
Cyclosporine A for Duchenne Muscular Dystrophy
Unfortunately, cyclosporine treatment had no effect on muscle power in children with Duchenne muscular dystrophy. -
Excessive Sleepiness and Narcolepsy: Clues from Genetics and Polysomnography
The accurate diagnosis of narcolepsy requires detailed history as well as physiological and genetic testing. -
Stroke Alert: A Review of Current Clinical Stroke Literature
-
Neurology Alert - Full January 2011 Issue in PDF
-
Non-adherence: A New Way to Measure
-
FDA Actions
-
Another Warfarin Replacement on Horizon
-
Pharmacology Watch - Full January 2011 Issue in PDF